Search
Tumor necrosis factor receptor superfamily member EDAR
go.drugbank.com/bio_entities/BE0021253TargetHumansReceptor for EDA isoform A1, but not for EDA isoform A2. Mediates the activation of NF-kappa-B and JNK. May promote caspase-independent cell death
Polypeptides: Tumor necrosis factor receptor superfamily member EDARSynonyms: EDA-A1 receptor, Ectodysplasin-A receptorT cell receptor beta variable 6-5
go.drugbank.com/bio_entities/BE0021562TargetHumansV region of the variable domain of T cell receptor (TR) beta chain that participates in the antigen recognition (PubMed:24600447).
Polypeptides: T cell receptor beta variable 6-5Ethinylestradiol
go.drugbank.com/drugs/DB00977ApprovedInvestigational[A191107] It was developed in an effort to create an estrogen with greater oral bioavailability. … [A191107] These properties were achieved by the substitution of an ethinyl group at carbon 17 of [estradiol].[A191107] Ethinylestradiol soon replaced [mestranol] in contraceptive pills.
Mixtures: Min-ovral 21, Min-ovral 28Categories: Hormonal Contraceptives for Systemic Use, P-glycoprotein substratesAzficel-T
go.drugbank.com/drugs/DB11051ApprovedWithdrawnAzficel-T is an autologous cellular product composed of fibroblasts indicated for improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults. … Azficel-T is marketed in the US as Laviv for intradermal injection.
Ferric chloride
go.drugbank.com/drugs/DB15536ApprovedMixtures: Addaven Konzentrat zur Herstellung einer Infusionslösung, Addaven Concentrate for Solution for InfusionAcetohydroxamic acid
go.drugbank.com/drugs/DB00551ApprovedInvestigationalIn the urine, it acts as an antagonist of the bacterial enzyme urease. Acetohydroxamic Acid has no direct antimicrobial action and does not acidify urine directly.
Echothiophate
go.drugbank.com/drugs/DB01057ApprovedInvestigationalA potent, long-acting irreversible cholinesterase inhibitor used as an ocular hypertensive in the treatment of glaucoma. Occasionally used for accomodative esotropia.
Anacaulase
go.drugbank.com/drugs/DB17449ApprovedInvestigationalThey also require specialized surgical personnel and facilities, and autologous skin grafting may be needed. Therefore, enzymatic alternatives such as anacaulase can lead to better clinical outcomes. … [L44717] Anacaulase is indicated for eschar removal in patients with deep partial thickness and/or full-thickness thermal burns.
Categories: Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2C9 InhibitorsSaxagliptin
go.drugbank.com/drugs/DB06335ApprovedInvestigationalSaxagliptin (rINN) is an orally active hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. FDA approved on July 31, 2009.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesNitrogen
go.drugbank.com/drugs/DB09152ApprovedInvestigationalVet approvedLiquid nitrogen is used principally in cryotherapy for removal of diseased skin.
Mixtures: SmofKabiven zentral elektrolytfrei Emulsion zur InfusionProducts: Stickstoff medizinisch Linde - Gas zur medizinischen Anwendung